In the dynamic realm of pharmaceutical manufacturing, the journey from raw materials to life-saving medications is intricate and relies heavily on a class of essential compounds known as pharmaceutical intermediates. These chemical building blocks, while not the final active ingredients themselves, are indispensable for the synthesis of Active Pharmaceutical Ingredients (APIs), which are the core components responsible for a drug’s therapeutic effect. Among these critical compounds is 14-tert-butoxy-14-oxo-tetradecanoic Acid, identified by CAS No. 234082-00-9, a versatile intermediate vital for various drug synthesis pathways.

14-tert-butoxy-14-oxo-tetradecanoic Acid boasts a molecular formula of C18H34O4 and a molecular weight of 314.46000. Its physical properties are well-defined, with a boiling point of approximately 417.4±18.0 °C and a density of 0.971±0.06 g/cm3. This compound typically presents as a white powder, ensuring ease of handling and consistent quality in manufacturing processes. With a purity of 98% minimum, it meets the rigorous standards required for pharmaceutical applications, making it a reliable choice for advanced chemical synthesis.

Pharmaceutical intermediates like 14-tert-butoxy-14-oxo-tetradecanoic Acid serve multiple crucial functions. They are the molecular precursors that undergo a series of precise chemical transformations to yield complex APIs. This multi-step synthesis approach is highly efficient, allowing for the controlled introduction of specific functional groups and molecular structures. By breaking down the complex drug synthesis into manageable stages, intermediates enable more effective quality control, ensuring the purity and consistency of the final API. Any impurities or variations at the intermediate stage can significantly impact the efficacy and safety of the end drug product, underscoring the paramount importance of high-quality intermediates.

Beyond synthesis, these intermediates play a significant role in pharmaceutical research and development. They are fundamental in improving the stability, solubility, and bioavailability of new drug formulations, ultimately boosting their effectiveness. The ability to produce intermediates in bulk contributes significantly to cost-effectiveness in drug manufacturing, making essential medicines more affordable and accessible globally. Furthermore, intermediates support the scalability of production, allowing pharmaceutical companies to transition from small-scale laboratory experiments to large-scale commercial manufacturing seamlessly to meet global demand.

The global pharmaceutical intermediates market is experiencing robust growth, driven by increasing demand for generic drugs, the rising prevalence of chronic diseases, and continuous advancements in drug discovery. This expansion highlights the need for reliable manufacturers and suppliers who can consistently deliver high-quality materials. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to meeting this demand by providing 14-tert-butoxy-14-oxo-tetradecanoic Acid with unwavering commitment to quality. Our rigorous quality control measures, including advanced analytical testing techniques such as chromatography and spectroscopy, ensure that every batch adheres to the highest industry standards for purity, consistency, and stability.

Choosing the right manufacturer and supplier for critical pharmaceutical intermediates is paramount. NINGBO INNO PHARMCHEM CO.,LTD. offers competitive pricing for 14-tert-butoxy-14-oxo-tetradecanoic Acid, with flexible packaging options from 25g to bulk quantities to suit diverse manufacturing needs. For those looking to buy or purchase this essential compound, our company stands as a trusted manufacturer and supplier, committed to facilitating efficient and safe drug development. We understand the stringent requirements of the pharmaceutical industry and are poised to be your reliable partner in sourcing high-quality intermediates.